Skip to main content
. 2014 Oct 2;33(1):83. doi: 10.1186/s13046-014-0083-8

Figure 3.

Figure 3

Survival analysis in patients under adjuvant 5-FU/FA/irinotecan in relation to AREG/EREG- expression. A. Disease-free survival in relation to AREG expression on tumor tissues. B. Disease-free survival in relation to EREG expression on tumor tissues. C. Disease-free survival in relation to AREG and EREG expression on tumor tissues.